Rockefeller Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.54K Buy
663
+530
+398% +$5.74K ﹤0.01% 4110
2025
Q4
$1.71K Buy
+133
New +$1.64K ﹤0.01% 4358
2023
Q1
Sell
-17
Closed 2062
2022
Q4
$0 Hold
17
﹤0.01% 3832
2022
Q3
$0 Sell
17
-38
-69% -$834 ﹤0.01% 3862
2022
Q2
$1K Buy
+55
New +$1.13K ﹤0.01% 3897

Other funds holding ANGO

Rockefeller Capital Management's ANGO Position: Q1 2026 in Review

Rockefeller Capital Management increased its AngioDynamics (ANGO) stake by 398% in Q1 2026, buying an estimated $5.74K and bringing the position to 663 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4110.

Rockefeller Capital Management first reported a position in ANGO in Q2 2022 and has held it in 5 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Rockefeller Capital Management held 663 shares of AngioDynamics worth $7.54K as of Q1 2026.
  • Rockefeller Capital Management bought 530 AngioDynamics shares in Q1 2026, an estimated $5.74K.
  • AngioDynamics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4110 holding.
  • Rockefeller Capital Management first reported a position in AngioDynamics in Q2 2022 and has held it in 5 quarters since.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.